City Therapeutics

City Therapeutics is at the forefront of biotechnology research, dedicated to engineering the future of RNAi-based medicines. With a focus on advancing next-generation engineering of small interfering RNAs (siRNAs), City Therapeutics aims to improve and expand the reach of RNAi-based treatments. The company's mission is to unlock RNAi's transformative potential, helping patients with a wide range of diseases.

Driven by pioneering executives and scientists in the field of RNAi, City Therapeutics is committed to building the leading next-generation RNAi therapeutics company. The company's innovative approach to siRNA technology is poised to revolutionize the treatment of various diseases.

City Therapeutics is dedicated to making a significant impact on global healthcare through its cutting-edge research and development efforts. We invite the management of City Therapeutics to create a customized and exclusive company showcase and product listing on our platform, further highlighting their advancements in biotechnology research.